Maria Von Med-Biotechnology Co., Ltd. is an emerging biopharmaceutical company established in Taiwan in 2008. Since its establishment, Maria Von has worked to develop cell-based therapeutics aiming to serve the world market. Using human cells and tissues, our adopted regenerative medicine approach aims to restore and regenerate damaged cells and tissues to their original states. The company is dedicated to the research, development and commercialization of innovative treatments for unmet medical needs and age-related degeneration; as well as to generate substantial value for our shareholders while complying with legal statutes and ethical guidelines.
Maria Von develops cell-based regenerative medicine, aims to fulfill unmet medical needs, and improve quality of life for the human race.
Achieve leadership in the regenerative medicine industry in Asia, provide personalized cell-based regenerative medicine.
Through our transformational regenerative medicine approach, we are making hope a reality for patients in the need.
MV Platelet Rich Plasma PRP Kit is a Class II medical device designed for fast, efficient and safe PRP collection and preparation. Platelets have regenerative and healing properties. PRP therapy and PRP injections, alone and in combination with other cells, are the most widely used cell therapies in regenerative medicine.
Along with Maria Von's stem cell culture technology, Maria Von provides adult stem cell culture services, provides personalized biologics in compliance with regulations, as the clinical applications of regenerative medicine.
For cell base products' safety and quality assurance purposes, Maria Von offers customized cell testing services to fully characterize your cells at multiple time points to ensure cell viability, cell identity and lack of contamination, all done at our Good Tissue Practice GTP facility.
Maria Von provides regulatory and product consulting services for biologics, pharmaceutical and medical devices; the go-to partner for companies seeking to bring innovative, safe and effective products to markets in Taiwan.
Maria Von is the leading adult stem cell bank in Taiwan. Maria Von's stem cell processing and banking methods ensure the genetic integrity and uniformity of an individual's cells in qualities and quantities for potential future therapeutic use.
Amniotic tissue can be used for clinical transplantation, is currently used for corneal transplant surgery. TFDA approved Maria Von tissue bank stores and supplies amniotic membrane transplants clinical use.
A culture committed to putting patients first.
Founding Scientist & Chairman
Mei-Yue Huang, MD, PHD, founder of Maria Von, has served as the Chairman of the Board since 2008. Prior to founding Maria Von Med-Biotech, Dr. Huang established Mainz Medical Aesthetic Enterprise in 1988. Dr. Huang was the Director of the Department of Dermatology at Taipei City Hospital Yangming Branch; and physician at Chang Gung Memorial Hospital, and Taipei Veterans General Hospital.
Dr. Huang holds a MD and a PHD from Johannes Gutenberg-Universität Mainz, Germany; as well as a MB from Kaohsiung Medical University, Taiwan.
Wen-Zern Hwang, MD, has served as Maria Von’s Scientific Advisor since 2008. Dr. Hwang’s clinical expertise is in brain and spinal surgery, particularly microscopic spinal surgery; he is the Director of the Department of Neurosurgery at Taiwan Adventist Hospital. He was the Director of the Department of Neurosurgery at Taipei City Hospital Yangming Branch, Taiwan; and physician at Minei Daiichi Hospital and Kenritsu Chubu Hospital, Japan.
Dr. Hwang holds a MD and MB from Kanazawa University, Japan.
Shih-Wei Yeh, MD, DMSc, has served as Maria Von’s Scientific Advisor since 2008. Dr. Yeh specializes in treating diseases and disorders of the skin, hair, nails, veins, and nearby tissues, as well as benign and malignant growths and skin cancers.
10F., No.29-1, Ln.169, Kangning St.,
Xizhi, New Taipei City, Taiwan